1. 疾病领域
  2. 代谢或内分泌疾病

Metabolic or Endocrine Disease  (代谢或内分泌疾病)

代谢或内分泌疾病涉及身体正常的宏量营养素处理和分配中断,通常由异常生化反应或遗传基因缺陷引起,导致嗜睡、体重减轻、黄疸和癫痫等多种症状。内分泌疾病是由于内分泌腺激素分泌过多或不足导致激素失衡而引起的非传染性疾病,导致 2 型糖尿病和甲状腺功能减退等疾病,久坐不动的生活方式常常会使病情恶化。

Metabolic or endocrine diseases involve disruptions in the body's normal processing and distribution of macronutrients, typically caused by abnormal biochemical reactions or inherited genetic defects, leading to diverse symptoms such as lethargy, weight loss, jaundice, and seizures. Endocrine diseases are noncommunicable disorders caused by hormonal imbalances due to overproduction or underproduction of hormones by endocrine glands, leading to conditions such as Type-2 diabetes and hypothyroidism, often worsened by a sedentary lifestyle.

Metabolic or Endocrine Disease (2):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17386
    Rosiglitazone

    罗格列酮

    122320-73-4 99.94%
    Rosiglitazone (BRL 49653) 是一种具有口服活性的 PPARγ 选择性激动剂 (EC50: 60 nM, Kd: 40 nM)。Rosiglitazone 是一种 TRPC5 激活剂 (EC50: 30 μM) 和 TRPM3 抑制剂。Rosiglitazone 可用于肥胖、糖尿病、衰老、卵巢癌的研究。
    Rosiglitazone
  • HY-N0385
    Gomisin J

    戈米辛J

    66280-25-9 99.97%
    Gomisin J 是一五味子来源的木脂素,可靶向 eNOSAMPK (LKB1CaMKIIβ)、fetuin-ANF-κBNrf2/HO-1 等多个靶点,且能通过血脑屏障。Gomisin J 通过激活 eNOS 增加 NO 生物利用度、激活 AMPK 通路调节脂代谢、抑制 fetuin-A 和 NF-κB 发挥抗炎作用、激活 Nrf2/HO-1 增强抗氧化能力等机制。Gomisin J 具有抗高血压、调节肝脂代谢、减轻脑缺血再灌注损伤等活性,可用于高血压、非酒精性脂肪肝、脑缺血再灌注损伤等研究。
    Gomisin J